Exchange: NASDAQ·Updated 07:42 PM EDT
REPL logo

REPL Replimune Group Inc

$15.61
$0.37
(2.42%)
Today
Closed $15.67
$0.0592
(0.38%)
After Hours
Reported EarningsAug 14
Mkt Cap$1.44B
Vol1.78M

About REPL

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.
67

Bullish Sentiment

How do you feel about REPL?

Advertisement|Remove ads.